Ares Capital Corporation (ARCC) Stock Analysis
Market Closed
Sector: Other
What's happening with ARCC
Price History
5-Year Weekly Candlestick Chart
Profile
growth and financial health lag behind.
How is each axis scored?
- Valuation50/100 · Moderate
- P/E vs own history (83th pct)0/25
- FCF yield (n/a)10/25
- P/S (4.6x)20/25
- EV/EBIT (13.0x)20/25
- Growth40/100 · Weak
- Revenue CAGR (13.8%)20/25
- Net income CAGR (-4.6%)0/25
- EPS CAGR 5Y (-14.7%)0/25
- Fwd implied growth (24.3%)20/25
- Profitability67/100 · Moderate
- ROIC (6.0%)5/25
- ROE (8.2%)12/25
- Net margin (37.7%)25/25
- Operating margin (73.8%)25/25
- Financial Health46/100 · Weak
- Altman Z (0.54)3/25
- Current ratio (1.67)18/25
- Interest coverage (1458.0x)25/25
- Net cash / debt (D/A 50%)0/25
- Quality55/100 · Moderate
- Piotroski F (3/9)5/25
- Beneish M (-2.52)25/25
- FCF conversion (n/a)0/25
- Margin stability (σ 4.7%)25/25
About Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Show more
Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.
Headquarters: NEW YORK, NY · Employees: 4,250 · Website ↗
Analyst Consensus
Strong BuyWall Street consensus estimates — not a PMP forecast · Updated Sep 21, 2026
Insider Transactions
Recent SEC Form 4 filings
- BuyOpen market buy · filed 2026-02-10+15.0K sh2026-02-09
- BuyOpen market buy · filed 2026-02-09+5.2K sh2026-02-06
- BuyOpen market buy · filed 2026-02-09+12.5K sh2026-02-05
- BuyOpen market buy · filed 2026-02-09+4.0K sh2026-02-05
- BuyOpen market buy · filed 2026-02-09+12.5K sh2026-02-05
+1 more recent filings
Key Metrics
Financial snapshot — pillar inputs plus per-share and market context
Valuation
50CP/E (TTM)12.2xA
Grade A: CheapPrice / TTM EPS (own statements) — vs own 5Y history: 4.8x–18.5x · 83rd pct
P/FCF26.8xB
Grade B: FairPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield3.7%C
Grade C: LowTTM FCF / Market Cap
P/S (TTM)4.58xB
Grade B: FairPrice / TTM Revenue (own statements) — vs own 5Y history: 4.0x–5.6x · 22nd pct
EV/EBIT13.0xB
Grade B: FairEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 11.9x–19.4x · 36th pct
EV/Sales9.4xC
Grade C: Exp.Enterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E9.8xA
Grade A: CheapPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio0.99xA
Grade A: FairPrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio-12.71A
Grade A: CheapFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield9.53%C
Grade C: HighTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio97.3%D
Grade D: Unsust.Dividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
67BROIC6.0%D
Grade D: LowNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE8.2%D
Grade D: WeakReturn on Equity. Neg. equity = heavy buybacks
ROA3.1%D
Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin37.7%A
Grade A: HighNet Income / Revenue
Operating Margin73.8%A
Grade A: HighTTM EBIT / TTM Revenue
Gross Margin100.0%A
Grade A: PremiumGross Profit / Revenue
FCF Margin—
FCF / Revenue
True FCF Margin—
TTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Financial Health
46D+Altman Z-Score0.54D
Grade D: DistressBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.67xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio1.67xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage1458.0xA
Grade A: StrongEBIT/Interest. >10 Strong
Debt Repayment—
Years to repay net debt via FCF
Net Debt/EBIT6.8xD
Grade D: HighLeverage. <2x Low, >4x High
Debt/Equity1.13xC
Grade C: MedDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.03xD
Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash
Growth
40D+Revenue CAGR13.8%C
Grade C: OkCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR-4.6%D
Grade D: LowCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)-14.7%D
Grade D: LowCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Forward Growth24.3%C
Grade C: MedImplied 1Y EPS growth from forward P/E vs our TTM EPS. Sparse — only where forward estimates exist
Dilution (5Y)—
Share count change over 5Y
SBC / Net Income—
Stock-based comp/Net income. >30% = dilution risk
SBC / Revenue—
TTM stock-based comp / TTM Revenue
Quality
55CPiotroski F-Score3/9D
Grade D: WeakFinancial strength 0–9. >7 Strong
Beneish M-Score-2.52A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion—
FCF / Net Income
Margin Stability4.7%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue—
TTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.10xD
Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Per Share
EPS (TTM)$1.60
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$0.89
Cash & short-term investments per share (Finnhub)
Book Value / Share$19.94
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$15.85B
Total debt obligations (short + long term)
Cash & Equiv.$505.00M
Cash and short-term investments
Net Debt$15.34B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$14.06B
Shareholders' equity (book value)
Asset / Liability1.85xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$13.98B
Current Market Capitalization
Beta0.67B
Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
Takeaway
Napriek solídnej profitabilite (P: 67) predstavuje ARCC kvôli kriticky nízkemu Altmanovmu skóre (0,54) a slabšiemu finančnému zdraviu (H: 46) vysoké bilančné riziko.
Current P/E of 12.2x sits at the 83rd percentile of its historical range.
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Mar 2026 · Ratio snapshot Sep 22, 2026
Key Insights: Ares Capital Corporation (ARCC)
Composite verdict for Ares Capital Corporation: Napriek solídnej profitabilite (P: 67) predstavuje ARCC kvôli kriticky nízkemu Altmanovmu skóre (0,54) a slabšiemu finančnému zdraviu (H: 46) vysoké bilančné riziko.. Ares Capital Corporation meets only 3 of 9 Piotroski F-Score criteria — a sign of weak underlying fundamentals. Altman Z-Score of 0.54 is below the 1.81 distress threshold — an elevated financial-risk flag.
- Beneish M-Score of -2.52 suggests a low likelihood of earnings manipulation.
- The stock currently yields 9.5% in dividends.
See how ARCC ranks on the Capex Tracker — top 50 capital spenders compared.
No significant market moves for ARCC in the last 30 days.
See ARCC move history →Frequently Asked Questions about ARCC
Is ARCC stock a buy right now?
PreMarketPrice's quantitative model rates Ares Capital Corporation's financial health at 46/100 — Napriek solídnej profitabilite (P: 67) predstavuje ARCC kvôli kriticky nízkemu Altmanovmu skóre (0,54) a slabšiemu finančnému zdraviu (H: 46) vysoké bilančné riziko.. This is a data-driven snapshot of fundamentals, not investment advice.
Is ARCC stock overvalued?
Ares Capital Corporation trades at a trailing P/E of 12.2 and our valuation score rates it 50/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Ares Capital Corporation report earnings?
No confirmed earnings date is currently scheduled for ARCC. The Earnings section lists recent reports and updates as dates are announced.
What sector does Ares Capital Corporation operate in?
Ares Capital Corporation operates in the Other sector. The Related Stocks section lists sector peers for comparison.
What does Ares Capital Corporation do?
Ares Capital Corp is a United States-based closed-ended specialty finance company.
About Ares Capital Corporation (ARCC) Stock
Ares Capital Corporation (ARCC) is a US-listed stock operating in the Other sector. Real-time pricing data for Ares Capital Corporation is available on this page with a market capitalization of $14.0 billion. The financial health score for ARCC is 46/100, which indicates moderate financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for ARCC stock.
ARCC Stock Analysis & Key Metrics
On PreMarketPrice, you can track Ares Capital Corporation (ARCC) across multiple dimensions:
- Pre-market price & movement: Real-time ARCC stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for ARCC with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Ares Capital Corporation across multiple reporting periods.
- Financial health score: A composite score of 46/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for ARCC.
- Sector peers: Compare ARCC against 7 other other stocks on key financial metrics.
Is ARCC a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Ares Capital Corporation (ARCC) as an investment. The financial health score of 46/100 suggests moderate financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Ares Capital Corporation (ARCC) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.